Stanford University
Showing 3,601-3,700 of 13,137 Results
-
Xiaojing Gao
Assistant Professor of Chemical Engineering
Current Research and Scholarly InterestsHow do we design biological systems as “smart medicine” that sense patients’ states, process the information, and respond accordingly? To realize this vision, we will tackle fundamental challenges across different levels of complexity, such as (1) protein components that minimize their crosstalk with human cells and immunogenicity, (2) biomolecular circuits that function robustly in different cells and are easy to deliver, (3) multicellular consortia that communicate through scalable channels, and (4) therapeutic modules that interface with physiological inputs/outputs. Our engineering targets include biomolecules, molecular circuits, viruses, and cells, and our approach combines quantitative experimental analysis with computational simulation. The molecular tools we build will be applied to diverse fields such as neurobiology and cancer therapy.
-
Yifan Gao
Postdoctoral Scholar, Microbiology and Immunology
BioDr. Yifan Gao is a postdoctoral researcher at Stanford University School of Medicine in the Department of Microbiology and Immunology under Prof. Justin Sonnenburg's advisement. Prior to joining Stanford, she received her Ph.D. from UCLA focusing on Environmental Microbiology and M.S. from UC Berkeley in Environmental Engineering.
-
Adrené Garabedian
Engagement Programs Manager, Emergency Medicine
Current Role at StanfordEmergency Medicine Strategy Manager
Faculty & Staff Engagement Program Manager & Co-Lead -
Zainab Garba-Sani
Affiliate, Health Policy
BioZainab Garba-Sani is a Stanford-affiliated Research Scholar and UK Commonwealth Fund Senior Harkness Fellow (2022–23), working at the intersection of health policy, science, and community-centred practice. Her work focuses on how emerging fields such as artificial intelligence, genomics, and regenerative medicine can be translated responsibly into real-world health impact - particularly for underserved populations and people living with chronic and rare conditions.
Her research and practice are grounded in bridging cutting-edge science and innovation with lived experience - focusing on inclusive design, governance, and real-world implementation. She is the founder of ACCESS AI, an initiative advancing equitable and inclusive approaches to health AI through diverse community engagement, meaningful co-production, and interdisciplinary collaboration. Through this work, she contributes to broader conversations on AI governance, data equity, and the societal implications of innovation.
Alongside this, Garba-Sani collaborates internationally with academic institutions, healthcare systems, civil society, industry, and governments to strengthen innovation pathways and care models for sickle cell and other historically neglected populations, including in low-and middle- income countries. She holds senior advisory and leadership roles across health and research ecosystems and is an advisor to multiple committees focused on gene and cell therapies, regenerative medicine, health equity, and rare diseases. She is Vice Chair of the Sickle Cell Society and was recently the Founding Chair of NHS England’s Sickle Cell Transformation Patient Advisory Group and Co-Chair of Genomics England’s Diverse Data Advisory Board.
Garba-Sani holds an MSc in Health Policy from Imperial College London and brings extensive experience in healthcare leadership, having previously served in senior roles at NHS England, TEDxNHS, and the NHS Muslim Network. Her contributions have been recognised with numerous awards, including the UK Prime Minister’s Points of Light Award. -
Alan M. Garber
Henry J. Kaiser Jr. Professor and Professor of Medicine, Emeritus
Current Research and Scholarly InterestsTopics in the health economics of aging; health, insurance; optimal screening intervals; cost-effectiveness of, coronary surgery in the elderly; health care financing and delivery, in the United States and Japan; coronary heart disease
-
Cathy Garcia
Postdoctoral Scholar, Stanford Cancer Institute
Current Research and Scholarly InterestsIslet biology, diabetes, obesity, pancreatic cancer
-
Chris Garcia
Younger Family Professor and Professor of Structural Biology
Current Research and Scholarly InterestsStructural and functional studies of transmembrane receptor interactions with their ligands in systems relevant to human health and disease - primarily in immunity, infection, and neurobiology. We study these problems using protein engineering, structural, biochemical, and combinatorial biology approaches.
-
Gabriel Garcia, MD
Professor of Medicine (Gastroenterology and Hepatology) at the Stanford University Medical Center, Emeritus
Current Research and Scholarly InterestsThe natural history of common viral liver diseases of man is poorly understood, despite the fact that chronic liver diseases of man may result in death from liver failure or hepatocellular carcinoma.
-
Patricia Garcia
Clinical Associate Professor, Medicine - Gastroenterology & Hepatology
BioPatricia Garcia, MD is a board certified gastroenterologist and clinical informaticist. She is fellowship trained in neurogastroenterology and specializes in treating disorders of gastrointestinal motility including trouble swallowing, heartburn, reflux, constipation, fecal incontinence and pelvic floor dysfunction. She is also passionate about using digital health technologies and artificial intelligence to improve clinician and care team burden and burnout.
-
Leonor García-Bayona
Assistant Professor of Microbiology and Immunology
Current Research and Scholarly InterestsThe human microbiome is evolving rapidly (i.e. over our lifetimes) following changes in modern lifestyles, especially in industrialized countries. The García-Bayona lab seeks to understand how horizontal gene transfer shapes interactions within the human intestinal microbiota and what the implications of this widespread phenomenon are for community properties relevant to human health (for example, the ability of the gut community to recover after antibiotic treatment). There is currently only a superficial understanding of the different cellular roles of most exchanged genes, the mechanisms governing their spread and their effect community dynamics. Our lab works on bridging the existing gap between the current systems-level observational studies and a mechanistic understanding through bacterial genetics and physiology. We take a bottom-up approach (from genes to communities), incorporating genetics, metagenomics, population analyses and experimental evolution in tractable bacterial consortia.
-
Manuel Garcia-Careaga
Current Research and Scholarly InterestsGastroenterology, liver disease in cystic fibrosis patients, percutaneous gastrostomy tube in pediatric population, inflamatory bowel disease, failure to thrive
-
Christopher Gardner
Rehnborg Farquhar Professor
Current Research and Scholarly InterestsThe role of nutrition in individual and societal health, with particular interests in: plant-based diets, differential response to low-carb vs. low-fat weight loss diets by insulin resistance status, chronic disease prevention, randomized controlled trials, human nutrition, community based studies, Community Based Participatory Research, sustainable food movement (animal rights and welfare, global warming, human labor practices), stealth health, nutrition policy, nutrition guidelines
-
Michael J. Gardner, MD
Hatim and Durriya Tyabji Endowed Professor
Current Research and Scholarly InterestsDr. Gardner’s investigative program during his academic career has involved a two-pronged approach, including both clinical and basic research. Prior to joining the Orthopaedic Department at Stanford, he was the Director of the Orthopaedic Trauma Research Program at Washington University School of Medicine in St. Louis, MO. During his tenure as Director, he organized a highly productive and efficient research program. This resulted in publication of many scientific manuscripts, and numerous ongoing multicenter and single center trials that remain active.
Throughout his career, he has published over 100 peer-reviewed original scientific manuscripts, in addition to over 50 invited manuscripts, brief reports, and review papers. He has edited two published text books, is currently editing two more books, and has co-authored over 30 book chapters. His goals include continuing to be highly active in both clinical and basic research, and to continue attaining grant funding to support this work. -
Rebecca M. Gardner
Ph.D. Student in Epidemiology and Clinical Research, admitted Autumn 2022
BioMy research interests are in maternal nutrition and well-being, with a current focus on hyperemesis gravidarum (HG)—severe nausea and vomiting during pregnancy that often causes significant maternal undernutrition and poor antepartum and postpartum mental health, and is the leading cause of hospitalization in early pregnancy. I study HG from several angles: the environmental exposures that may exacerbate it, including ambient air pollution and wildfire smoke, and whether these contribute to HG-related hospitalization; and its downstream consequences for both mothers and children, including hypertensive disorders of pregnancy such as preeclampsia, preterm birth, and neurodevelopmental conditions in childhood such as autism. More broadly, I am interested in hypertensive disorders of pregnancy, preterm birth, and gestational diabetes, and their subsequent effects on offspring. Methodologically, I am drawn to applying causal inference methods traditionally used in economics to questions in public health.
Before starting a PhD, I was a biostatistician in the Quantitative Sciences Unit at Stanford for four years where I co-authored over thirty publications, collaborating with clinicians on various domains including developmental behavioral pediatrics, reproductive endocrinology & infertility, oncology, and clinical trials. I completed my MS in Statistics at Brigham Young University in 2016, where I collaborated with cardiologists to develop a new approach to diagnose rheumatic heart disease in pediatric patients in Samoa for my Master's thesis. -
Joseph Garner
Professor of Comparative Medicine and, by courtesy, of Psychiatry and Behavioral Sciences
Current Research and Scholarly InterestsThe medical research community has long recognized that "good well-being is good science". The lab uses an integrated interdisciplinary approach to explore this interface, while providing tangible deliverables for the well-being of human patients and research animals.
-
Matthias Garten
Assistant Professor of Microbiology and Immunology and of Bioengineering
Current Research and Scholarly InterestsWith a creative, collaborative, biophysical mindset, we aim to understand the ability non-model organisms to interface with environment to a point at which we can exploit the mechanisms finding cures against diseases and use the mechanisms as tools that we can use to engineer the environment. By developing approaches that allow a quantitative understanding and manipulation of molecular transport our research makes non-model organisms accessible to researchers and engineers.
Specifically, we are studying how the malaria parasite takes control over red blood cells. By learning the biophysical principles of transport in between the host and the parasite we can design ways to kill the parasite or exploit it to reengineer red blood cells. The transport we study is broadly encompassing everything from ions to lipids and proteins. We use variations of quantitative microscopy and electrophysiology to gain insight into the unique strategies the parasite evolved to survive. -
Olya Gary
Web Designer 3, OHNS/Otolaryngology/Head & Neck Surgery
Current Role at StanfordAs a senior web designer at Otolaryngology — Head & Neck Surgery Department and a member of the OHNS web team, I support the entire department web presence: http://med.stanford.edu/ohns.html.
I oversee a large number of projects related to the main OHNS site, research lab Wordpress sites, work on the website updates, and create visuals and photographs highlighting the department teams and places. I work with a large number of the department team members - from the administrative staff to the faculty members. -
Sergios Gatidis
Associate Professor of Radiology (Pediatric Radiology)
BioDr. Gatidis completed his medical training at the University of Tuebingen / Germany and received his Diploma in Mathematics from from the Universities of Tuebingen and Hagen / Germany. His research is focused on on methods and applications of machine learning for medical data analysis and translation of AI into clinical practice.
-
Brice Gaudilliere
Professor of Anesthesiology, Perioperative and Pain Medicine (MSD) and, by courtesy, of Pediatrics (Neonatology)
Current Research and Scholarly InterestsThe advent of high dimensional flow cytometry has revolutionized our ability to study and visualize the human immune system. Our group combines high parameter mass cytometry (a.k.a Cytometry by Time of Flight Mass Spectrometry, CyTOF), with advanced bio-computational methods to study how the human immune system responds and adapts to acute physiological perturbations. The laboratory currently focuses on two clinical scenarios: surgical trauma and pregnancy.
-
Dyani Gaudilliere
Clinical Associate Professor, Surgery - Plastic & Reconstructive Surgery
BioDr. Dyani Gaudilliere specializes in Dental Surgery and Oral Oncology in a hospital setting. As a hospital dentist she performs surgical treatment of infection and trauma to the teeth and supporting alveolar bone. She also performs medically necessary dental clearance and extractions in the context of larger medical conditions, such as cardiac disease, joint replacement, or organ transplantation. As an oral oncologist, she specializes in surgical dental treatment prior to, during, and following radiation therapy and chemotherapy.
-
Benny Gavi, MD, MTS
Clinical Assistant Professor, Medicine
Current Research and Scholarly InterestsHospitalist Medicine
Medicine Consultation
Quality Improvement
Medical Ethics
Organizational Ethics
Medical Humanities -
Charles Gawad
Associate Professor of Pediatrics (Hematology/Oncology)
BioOur lab works at the interface of biotechnology, computational biology, cellular biology, and clinical medicine to develop and apply new tools for characterizing genetic variation across single cells within a tissue with unparalleled sensitivity and accuracy. We are focused on applying these technologies to study cancer clonal evolution while patients are undergoing treatment with the aim of identifying cancer clonotypes that are associated with resistance to specific drugs so as to better understand and predict treatment response. We are also applying these methods to understand how more virulent pathogens emerge from a population of bacteria or viruses with an emphasis on developing a deeper understanding of how antibiotic resistance develops.
-
Michael W. Gaynon, MD
Clinical Professor, Ophthalmology
Current Research and Scholarly Interests-Retinal Vascular Disease
-Angiogenesis
-Retinopathy of Prematurity
-Sustained Release Drug Delivery Systems -
Sharon Markham Geaghan
Associate Professor of Pathology at the Stanford University Medical Center, Emerita
Current Research and Scholarly InterestsPediatric Hematopathology, Pediatric Laboratory Medicine and Pathology
-
Benedikt Geier
Postdoctoral Scholar, Infectious Diseases
BioB.Sc. Biology, Ludwig Maximilian University (LMU), Munich/Germany (2013)
M.Sc. Biology and bioimaging, Ludwig Maximilian University (LMU), Munich/Germany (2015)
Ph.D., Animal-Microbe Symbioses, Max Planck Institute for Marine Microbiology in Bremen/Germany (2020)
Benedikt joined the Amieva Lab from Germany in 2022. During his B.Sc. and M.Sc. programs in zoology, he became fascinated with 3D imaging approaches to study small animal microanatomy. He spent his PhD developing in situ imaging approaches to study deep-sea symbioses and fell in love with studying host-microbe interactions. In the Amieva Lab, Benedikt will advance his previously developed correlative chemical imaging techniques to resolve metabolic and cellular interactions that drive H. pylori pathogenesis in the gastric glands.
More about Benedikt's transition from deep-sea microbiology into infectious disease research can be found here:
https://scopeblog.stanford.edu/2022/08/24/unconventional-paths-deep-sea-to-the-stomach/ -
Pascal Geldsetzer
Assistant Professor of Medicine (Primary Care and Population Health) and, by courtesy, of Epidemiology and Population Health
BioPascal Geldsetzer is an Assistant Professor of Medicine in the Division of Primary Care and Population Health and, by courtesy, in the Department of Epidemiology and Population Health. He is also affiliated with the Phil & Penny Knight Initiative for Brain Resilience at the Wu Tsai Neurosciences Institute, Department of Biomedical Data Science, Department of Health Policy, and the Stanford Center for Population Health Sciences.
His research focuses on identifying and evaluating the most effective interventions for improving health at older ages. In addition to leading several randomized trials, his methodological emphasis lies in the use of natural experiments to ascertain causal effects in large observational datasets, particularly in electronic health record data. He has won an NIH New Innovator Award (in 2022), a Chan Zuckerberg Biohub investigatorship (in 2022), and three NIH R01 grants as Principal Investigator (in 2023 and 2024). In 2026, he was named one of the 100 most influential people in health and medicine globally by TIME Magazine. -
Margarita Geleta
Graduate, Biomedical Data Science
BioMargarita Geleta is a computer science PhD student at University of California, Berkeley (major in Artificial Intelligence and minor in Human-Computer Interaction), and a graduate exchange student at Stanford University. Ms. Geleta received her M.S. in computer science at University of California, Berkeley.
-
Linda N. Geng, MD, PhD
Clinical Associate Professor, Medicine - Primary Care and Population Health
Current Research and Scholarly InterestsMy scholarly focus is on puzzling and complex conditions. Our work aims to improve patients' diagnostic journeys, characterize poorly understood diseases, discover biological mechanisms, find treatments, improve care models, and reach communities in need.
With the COVID pandemic, the puzzling and complex illness of Long COVID or post-acute COVID-19 syndrome (PACS) emerged. Together with a multidisciplinary group of physicians and researchers, we launched a program here at Stanford to advance the care and understanding of Long COVID. Our goal is to better understand the natural history, clinical symptomatology, immunological response, risk factors, and subtypes of Long COVID. We are also actively assessing treatment strategies for Long COVID and developing care pathways and tools for clinicians to help their patients with this and other related infection-associated chronic illnesses.
